financetom
Business
financetom
/
Business
/
Funding Rundown: Tala raises $145M, PharmEasy gets $350M in pre-IPO round, says report & SaaS Labs bags $17M in Series A round
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Funding Rundown: Tala raises $145M, PharmEasy gets $350M in pre-IPO round, says report & SaaS Labs bags $17M in Series A round
Oct 18, 2021 10:31 AM

Here’s a lowdown of the top deals in the startup space.

Share Market Live

NSE

Tala raises $145M in funding round led by Upstart

Fintech company Tala has raised $145 million in Series-E funding round, led by Upstart with participation from the Stellar Development Foundation.

New investors Kindred Ventures and The J. Safra Group, along with existing investors including IVP, Revolution Growth, Lowercase Capital, and PayPal Ventures, also joined the round, which brings Tala's total funding to over $350 million.

Tala will use the investment to accelerate the roll-out of its new financial account experience all through Tala's consumer finance app. It will also grow its world-class team across Kenya, India, the Philippines, Mexico, and the US, and pull forward plans for both geographic and product expansion, including crypto offerings, the company said in a statement.

Also Read | OPPO India launches programme to mentor startups in India

The company entered India in 2020 and claims to have already had more than half a million users sign up for the platform.

Since launching in Nairobi in 2014, Tala claims to have delivered more than $2.7 billion in credit to more than six million customers across Kenya, the Philippines, Mexico, and India.

Leveraging the Stellar network, Tala also plans to use this funding to develop the first mass-market crypto product for emerging markets.

As part of this fundraising, Paul Gu, co-founder of Upstart, and Denelle Dixon, CEO and executive director of the Stellar Development Foundation have joined Tala's board of directors, the company added.

PharmEasy raises $350M in pre-IPO round: Report

IPO-bound online medical store PharmEasy has raised nearly $350 million ahead of filing their draft red herring prospectus (DRHP), as per Economic Times.

The company closed nearly $204 million (more than Rs 1,505 crore) in primary funding from Singapore’s Amansa Capital, Blackstone-backed hedge fund ApaH Capital, US hedge fund Janus Henderson, OrbiMed, Steadview Capital, Abu Dhabi’s sovereign wealth fund ADQ, hedge fund Neuberger Berman and London’s Sanne Group, the report added.

Also Read | India to get foreign inflows on preferred basis; startup economy big draw: Prime Securities

Nearly 20 senior employees bought shares worth $5 million as part of the secondary sale while early investors sold their stakes in the firm and IIFL’s tech fund has picked up some stake.

API Holdings, the parent company of PharmEasy has also raised $130-$140 million through secondary share sale, taking its post-money valuation to $5.6 billion, the report added.

Cloud-based platform SaaS Labs bags $17M in Series A round

Cloud-based platform SaaS Labs has bagged $17 million as part of its Series A funding round from San Francisco based early-stage venture capital firm Base10 Partners and Eight Roads Ventures.

The startup, which operates out of India, the Philippines, and the US, will use the fresh capital to expand its customer base, hire, and launch new products and services. The company is looking to double its 70-member team by the end of this year.

Founder Gaurav Sharma said the company has witnessed "unprecedented acceleration" of cloud adoption among SMBs in the last 12 months.

Also Read | View: Invest in new economy companies gradually over 2-3 years

SaaS Labs develops products for sales, support and marketing teams as well as contact centers to boost productivity. The company has two main products - Justcall and Helpwise.

Justcall, allows small and medium businesses (SMBs) to set up a cloud-based contact centre for sales or support, within minutes. It has native integrations with over 70 other business tools. Its other product, Helpwise, allows users to consolidate all communication streams in a single shared inbox, improving the quality and efficiency of customer support teams.

Automovill raises undisclosed funds from AngelBay

Full stack mobility startup Automovill has raised an undisclosed amount from AngelBay.

The round saw participation from Santosh Chandra, chief executive at Essar Oil & Gas Exploration and Production, and executives from Google and PWC. The round was a top up to the bridge round which brand raised in mid-July, the company said.

The firm provides tech-enabled solutions and B2B car service management. While the brand already has served 1,00,000+ orders across 12 cities, it plans to expand its footprint in other geographies, and deploy tech solutions. Automovill will use the funds to widen its wings in 20+ cities, and in ramping up infrastructure.

It plans to reach the 25,000-order mark, and presence across 20 cities by the end of current fiscal.

Numadic gets $2.5M funding from 9Unicorns: Report

Numadic, a vehicle interface platform, has raised $2.5 million in a funding round led by 9Unicorns and Venture Catalysts at a post-money valuation of $20 million, as per Economic Times.

Chona Family Office, as well as angel investors including Venture Catalysts founder Apoorva Ranjan Sharma and Spark Private Wealth participated in the funding round.

The capital will be used to acquire talent and technology and scale new products, the report added.

Cannabis e-commerce platform Dutchie raises $350M, valued at $3.75Bn

Cannabis e-commerce platform Dutchie has raised $350 million in its latest funding round that valued the company at $3.75 billion.

As per Reuters, the massive funding round is Dutchie’s second this year. The Bend, Oregon-based company raised $200 million in March when it was valued at $1.7 billion.

Dutchie’s latest funding round was led by venture capital firm D1 Capital Partners and previous investors, including Tiger Global, Dragoneer, DFJ Growth, Thrive Capital, and Snoop Dog’s Casa Verde Capital participated.

Lipson said the funding will be used to double down on research and development for its products. It takes a license fee from dispensaries that use the Dutchie e-commerce platform to sell to consumers. Lipson said the transactions were still mostly in cash as credit card networks have still not opened up for cannabis transactions.

(Edited by : Priyanka Deshpande)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Nov 17, 2025
02:58 PM EST, 11/17/2025 (MT Newswires) -- Jones Lang LaSalle ( JLL ) is set to benefit from improving industry tailwinds amid attractive valuation after its Q3 results, UBS Securities said in a Sunday note. The report pointed to an outlook downgrade for its Real Estate Management Services segment for the next several quarters while Q3 margin expansion disappointed, similar...
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Nov 17, 2025
03:04 PM EST, 11/17/2025 (MT Newswires) -- Liberty Defense Holdings ( LDDFF ) shares were up near 14% on Monday after it received a competitive bid award for three HEXWAVE walkthrough screening systems at a U.S. State Capitol complex in the Northeast. The company said the systems will support security screening for officials, employees, and visitors across two high-traffic buildings....
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Nov 17, 2025
02:46 PM EST, 11/17/2025 (MT Newswires) -- Target ( TGT ) is likely to post soft Q3 on Wednesday with comparable sales down about 2% and could narrow its fiscal 2025 earnings per share guidance toward the low end of its $7 to $9 range, Oppenheimer said Monday in a pre-results report. Oppenheimer said it added conservatism to its Q4...
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Nov 17, 2025
Jazz Pharmaceuticals Plc ( JAZZ ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). What Happened: When compared to the control group that received trastuzumab...
Copyright 2023-2025 - www.financetom.com All Rights Reserved